#cancerresearch
India Licenses SHetA2 Drug For Cervical Precancer Treatment
ICMR has licensed SHetA2 to Emcure for further development as a potential treatment for HPV-related cervical precancer, though it is not yet approved for patients. What Is SHetA2? SHetA2 is an investigational anti-HPV drug candidate being developed as a possible treatment for cervical intraepithelial neoplasia, commonly known as CIN. CIN refers to abnormal changes in the cells covering the cervix. These changes are not cancer, but high-
India Licenses SHetA2 Drug For Cervical Precancer Treatment
ICMR has licensed SHetA2 to Emcure for further development as a potential treatment for HPV-related cervical precancer, though it is not yet approved for patients. What Is SHetA2? SHetA2 is an investigational anti-HPV drug candidate being developed as a possible treatment for cervical intraepithelial neoplasia, commonly known as CIN. CIN refers to abnormal changes in the cells covering the cervix. These changes are not cancer, but high-
New pancreatic cancer drug shows major survival gains in Phase 3 study
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
New pancreatic cancer drug shows major survival gains in Phase 3 study
REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik









